|
1
|
World Health Organization (WHO): Global
Tuberculosis Control Report 2010. WHO; Geneva: 2010
|
|
2
|
US Agency for International Development:
Report to congress: Health-related research and development
activities at USAID-an update on the five-year strategy, 2006–2010.
US Agency for International Development. 182:1788–1790. 2009.
|
|
3
|
Tare P, China A and Nagaraja V: Distinct
and contrasting transcription initiation patterns at Mycobacterium
tuberculosis promoters. PLoS One. 7:e439002012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jia Y and Patel SS: Kinetic mechanism of
transcription initiation by bacteriophage T7 RNA polymerase.
Biochemistry. 36:4223–4232. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Martínez-Antonio A, Salgado H, Gama-Castro
S, et al: Environmental conditions and transcriptional regulation
in Escherichia coli: A physiological integrative approach.
Biotechnol Bioeng. 84:743–749. 2003. View Article : Google Scholar
|
|
6
|
Holley CL and Topkara VK: An introduction
to small non-coding RNAs: miRNA and snoRNA. Cardiovas Drugs Ther.
25:151–159. 2011. View Article : Google Scholar
|
|
7
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Baroni D and Arrigo P: MicroRNA target and
gene validation in viruses and bacteria. Methods Mol Biol.
1107:223–231. 2014. View Article : Google Scholar
|
|
9
|
Chinese Medical Association: TB volume of
clinical diagnosis and treatment guidelines. People's Medical
Publishing House; Beijing: 2005
|
|
10
|
World Medical Association: World Medical
Association Declaration of Helsinki: Ethical principles for medical
research involving human subjects. JAMA. 310:2191–2194. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huard RC, Lazzarini LC, Butler WR, van
Soolingen D and Ho JL: PCR-based method to differentiate the
subspecies of the Mycobacterium tuberculosis complex on the basis
of genomic deletions. J Clin Microbiol. 41:1637–1650. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bao X, Lian L, Xu D, et al: Rapid species
identification of 391 clinical Mycobacterium isolates from Anhui
province by multi-locus PCR. Chinese Journal of Zoonoses.
28:659–663. 2012.
|
|
13
|
Kozomara A and Griffiths-Jones S: miRBase:
Integrating microRNA annotation and deep-sequencing data. Nucleic
Acids Res. 39:D152–D157. 2011. View Article : Google Scholar :
|
|
14
|
Martin M: Cutadapt removes adaptor
sequences from high-throughput sequencing reads. EMBnetjournal.
17:10–12. 2011.
|
|
15
|
Langmead B, Trapnell C, Pop M and Salzberg
SL: Ultrafast and memory-efficient alignment of short DNA sequences
to the human genome. Genome Biol. 10:R252009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wojcicka A, Swierniak M, Kornasiewicz O,
et al: Next generation sequencing reveals microRNA isoforms in
liver cirrhosis and hepatocellular carcinoma. Int J Biochem Cell
Biol. 53:208–217. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nielsen CB, Shomron N, Sandberg R,
Hornstein E, Kitzman J and Burge CB: Determinants of targeting by
endogenous and exogenous microRNAs and siRNAs. RNA. 13:1894–1910.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
World Health Organization (WHO): Global
tuberculosis report, 2012. WHO; Geneva: 2012
|
|
19
|
Dye C, Espinal MA, Watt CJ, Mbiaga C and
Williams BG: Worldwide incidence of multidrug-resistant
tuberculosis. J Infect Dis. 185:1197–1202. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Raviglione MC, Gupta R, Dye CM and Espinal
MA: The burden of drug-resistant tuberculosis and mechanisms for
its control. Ann NY Acad Sci. 953:88–97. 2001. View Article : Google Scholar
|
|
21
|
Zumia A and Grange JM: Multidrug-resistant
tuberculosis - can the tide be turned? Lancet Infect Dis.
1:199–202. 2001. View Article : Google Scholar
|
|
22
|
World Health Organization (WHO):
Anti-tuberculosis drug resistance in the world: The WHO/IUATLD
global project on anti-tuberculosis drug resistance suveillance:
Third global report. WHO; Geneva: 2003
|
|
23
|
Banerjee R, Rudra P, Prajapati RK,
Sengupta S and Mukhopadhyay J: Optimization of recombinant
Mycobacterium tuberculosis RNA polymerase expression and
purification. Tuberculosis (Edinb). 94:397–404. 2014. View Article : Google Scholar
|
|
24
|
Artsimovitch I, Vassylyeva MN, Svetlov D,
et al: Allosteric modulation of the RNA polymerase catalytic
reaction is an essential component of transcription control by
rifamycins. Cell. 122:351–363. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Campbell EA, Korzheva N, Mustaev A, et al:
Structural mechanism for rifampicin inhibition of bacterial RNA
polymerase. Cell. 104:901–912. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Feklistov A, Mekler V, Jiang Q, et al:
Rifamycins do not function by allosteric modulation of binding of
Mg2+ to the RNA polymerase active center. Proc Natl Acad
Sci USA. 105:14820–14825. 2008. View Article : Google Scholar
|
|
27
|
Chopra I: Bacterial RNA polymerase: A
promising target for the discovery of new antimicrobial agents.
Curr Opin Investig Drugs. 8:600–607. 2007.PubMed/NCBI
|
|
28
|
Chopra I, Hesse L and O'Neill AJ:
Exploiting current understanding of antibiotic action for discovery
of new drugs. Symp Ser Soc Appl Microbiol. (31): 4S–15S. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Darst SA: New inhibitors targeting
bacterial RNA polymerase. Trends Biochem Sci. 29:159–160. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Villain-Guillot P, Bastide L, Gualtieri M
and Leonetti JP: Progress in targeting bacterial transcription.
Drug Discov Today. 12:200–208. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang J, Chiodini R, Badr A and Zhang G:
The impact of next-generation sequencing on genomics. J Genet
Genomics. 38:95–109. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Filipowicz W, Bhattacharyya SN and
Sonenberg N: Mechanisms of post-transcriptional regulation by
microRNAs: Are the answers in sight? Nat Rev Genet. 9:102–114.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lim LP, Lau NC, Garrett-Engele P, et al:
Microarray analysis shows that some microRNAs downregulate large
numbers of target mRNAs. Nature. 433:769–773. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jazdzewski K, Boguslawska J, Jendrzejewski
J, et al: Thyroid hormone receptor beta (THRB) is a major target
gene for microRNAs deregulated in papillary thyroid carcinoma
(PTC). J Clin Endocrinol Metab. 96:E546–E553. 2011. View Article : Google Scholar
|
